2024 - AvKare - Launch 08.06.24 - Pazopanib 200mg Tablet.pdf
3 day letter for VT_Cooper_Paragard_5129-01.pdf
3 Day Notice letter - Levorphanol.pdf
30dayVermontReport_2024.pdf
Adalimumab-aacf VT 3-day Notice.pdf
Bimzelx Vermont New Drug Notice.pdf
Cetrorelix VT 3-day Notice.pdf
Chartwell - VT New Drug Notice Report - 7.26.24 - Amantadine HCL OS.pdf
Chartwell - VT New Drug Notice Report - 8.02.24.pdf
Chartwell - VT New Drug Notice Report - 8.09.24.pdf
Chartwell - VT New Drug Notice Report - 8.29.24.pdf
Cobenfy_3 day Notice to Vermont_Bristol Myers Squibb.pdf
Drug Price Transparency - 3 Day Notice - VT Chlorpromazine.pdf
Drug Price Transparency - 3 Day Notice - VT Cyclophosphamide.pdf
Drug Price Transparency - 3 Day Notice - VT Diclofenac Potassium 25mg.pdf
Drug Price Transparency - 30 Day Notice - VT Calcitonin.pdf
Drug Price Transparency - 30 Day Notice - VT Cyclophosphamide.pdf
Drug Price Transparency - Report - VT Diclofenac Potassium 25mg.pdf
Endo USA Vermont State Notification - Tiopronin (July 2024).pdf
Endo_Vermont 30-Day Notice Template _Signed.pdf
For Approval - VT 3-Day New Drug_ANI_L-Glutamine Oral Powder.pdf
Hikma_Pryazinamide Tabs USP 500 mg 500_VT Product Notification 3 Day.pdf
ITF_VT_New Drug_APPROVED.pdf
ITF_VT_New Product_Duvyzat_APPROVED.pdf
Lazcluze Press Release.pdf
Micafungin VT New Product Report.pdf
New drug approval - Aqneursa from IntraBio Inc..pdf
New Drug Notice - Elfabrio 5mg.pdf
New_Prescription_Drug_Notice_7.8.24_to_the_state_of_VT_(Ss_4637).-30day..docx.pdf
Notice of Introduction of New Prescription Drug Sept 5 2024.pdf
Notice of New Drug Introduction Pursuant to 18 V.S.A § 4637(b) - FPP Lofexidine Tablets.pdf
Notice of New Drug Introduction Pursuant to 18 V.S.A § 4637(b) - Sagent Nelarabine Injection.pdf
Pangea VT 30 day Filing - Selenious Acid 400.pdf
Prasco VT Notice of Introduction of New Prescription Drug (lofexidine) 9 3 2024.pdf
Prasco, LLC's Additional Information After Initial Notice of New Drug.pdf
RE_ Galderma - Notification of New prescription drug.pdf
Sodium Phosphate 15mL 30-day Report - Vermont.pdf
Sodium Phosphate 5mL 30-day Report - Vermont.pdf
Tyenne VT 3-day Notice 7.10.2024.pdf
Tyenne VT 30-day Report 7.10.2024.pdf
Vermont - AGO - 3 day email information 9.11.2024.pdf
Vermont New Drug 3-day Notification.pdf
Vermont New High-Cost Drug 3-Day Notice - Novavax 80631-0107-10.pdf
Vermont New prescription drug notice.pdf
Vermont Notification New Drug RYTELO.pdf
Vermont Report_Amcinonide.pdf
Vermont Report_Lenalidomide.pdf
Vermont SDPT Initial Drug Notification - FH2 - Methocarbamol.pdf
Vermont SDPT Initial Drug Notification - Forte - Methocarbamol.pdf
Vermont SDPT Initial Drug Notification - Mirum - Livmarli.pdf
Vermont SDPT Summary Drug Notification - Mirum - Livmarli 19mg.pdf
Vermont – Prasco, LLC's Additional information after initial notice of New Drug_ Lofexidine Tablets - 0.18mg, 96 County.pdf
Vermont_New_Drug_30_Day_Submission_Report Levorphanol.pdf
Vermont_New_Drug_Notice.pdf
VT - Adalimumab Hulio - 30 Day Reporting.pdf
VT - New Drug Notice (30-day).pdf
VT - Novugen Sunitinib Capsules.pdf
VT 3 Day Epoprostenol 09-27-24.pdf
VT 3 Day Vancomycin Hydrochloride 7.26.24.pdf
VT 3-Day New Drug Notification_Gilead_LIVDELZI_61958-3301-01.pdf
VT 3-Day Notification_ANI_Inderal LA_2024 Launch.pdf
VT 30 Day File - Lazcluze.pdf
VT 30 Day Report_Rinvoq LQ.pdf
VT 30-day letter_Gilead_LIVDELZI.pdf
VT 30-Day New Drug_ANI_70954041720.pdf
VT Act 193 New Drug Notice Almirall Klisyri.pdf
VT Act 193 New Drug Notice.pdf
VT Act 193 New Drug Notice_.pdf
VT Act 193 New Drug Report - Almirall Klisyri Final.pdf
VT Act 193 New Drug Report - PCCFinal.pdf
VT Act 193 New Drug Report_8.27.24_MR_TN_Final.pdf
VT Act 193 New Drug Report_Voranigo_Final_9.6.2024.pdf
VT Letter to Office of Attorney General_New Drug Report Email - Potassium Phosphates.pdf
VT New Drug Notice 3 Day-PiaSky.pdf
VT New Drug Notice_Voranigo_Signed_8.9.2024.pdf
VT New Drug Notification and Report-Ebglyss.pdf
VT New Drug Notification and Report-Kisunla.pdf
VT New Drug Notification and Report-Retevmo tablets.pdf
VT New Drug Pricing Notice -Austedo XR Titration.pdf
VT New Drug Pricing Report - Mesalamine DR Tablets.pdf
VT New Drug Pricing Report - PACLITAXEL INJ ALB-BND.pdf
VT New Drug Pricing Report -Austedo XR 18mg.pdf
VT New Drug Pricing Report -Austedo XR 30, 36, 42, 48.pdf
VT New Drug Pricing Report -Austedo XR Titration July.pdf
VT New Drug Report.pdf
VT New Drug Reporting - Elfabrio 5mg.pdf
VT New Drug Reporting 30 Day-Piasky.pdf
VT Notice of New Drug Introduction - LISDEXAMFETAMINE DIM CHEW TABS.pdf
VT Notice of New Drug Introduction - Mesalamine DR Tablets.pdf
VT Notice of New Drug Introduction - PACLITAXEL INJ ALB-BND.pdf
VT Notice of New Drug Introduction -Austedo XR 18mg.pdf
VT Pharmaceutical Cost Transparency - Apotex Corp - Dasatinib Tablets - 30 Day Reporting.pdf
VT Pharmaceutical Cost Transparency - Apotex Corp - Dasatinib Tabs - 3 Day Reporting_09042024.pdf
VT Pharmaceutical Cost Transparency - Apotex Corp - Oxcarbazepine Tablets - 30 Day Reporting.pdf
VT Pharmaceutical Cost Transparency - Apotex Corp - Oxcarbazepine Tabs - 3 Day Reporting_09042024.pdf
VT Pharmaceutical Cost Transparency - Biocon Biologics Inc. - Hulio and Adalimumab Launch Reporting.pdf
Charity R. Clark
Office of the Vermont Attorney General